1031POCTAVE: A phase I study of enadenotucirev, an...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

1031POCTAVE: A phase I study of enadenotucirev, an oncolytic group B adenovirus, in combination with weekly paclitaxel in platinum-resistant epithelial ovarian cancer

McNeish, I A, Moreno, V, Jayson, G, Roxburgh, P, Ginesta, M P Barretina, Garcia-Donas, J, Torres, A Anton, Michael, A, Brown, R, Krige, D, Bendall, J, Di Genova, G, McElwaine-Johnn, H
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz250.039
Date:
October, 2019
File:
PDF, 70 KB
2019
Conversion to is in progress
Conversion to is failed